Dr. Reddy's Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Dr. Reddy's Laboratories has a total shareholder equity of ₹267.9B and total debt of ₹16.1B, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are ₹372.8B and ₹105.0B respectively. Dr. Reddy's Laboratories's EBIT is ₹67.5B making its interest coverage ratio -106.7. It has cash and short-term investments of ₹72.6B.
Key information
6.0%
Debt to equity ratio
₹16.14b
Debt
Interest coverage ratio | -106.7x |
Cash | ₹72.55b |
Equity | ₹267.85b |
Total liabilities | ₹104.99b |
Total assets | ₹372.84b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RDDA's short term assets (₹238.5B) exceed its short term liabilities (₹93.6B).
Long Term Liabilities: RDDA's short term assets (₹238.5B) exceed its long term liabilities (₹11.4B).
Debt to Equity History and Analysis
Debt Level: RDDA has more cash than its total debt.
Reducing Debt: RDDA's debt to equity ratio has reduced from 31.8% to 6% over the past 5 years.
Debt Coverage: RDDA's debt is well covered by operating cash flow (332%).
Interest Coverage: RDDA earns more interest than it pays, so coverage of interest payments is not a concern.